How much does lorlatinib/lorlatinib cost per month?

Lorlatinib (Lorlatinib) is a prescription drug used to treat adults with non-small cell lung cancer (NSCLC) caused by an abnormal anaplastic lymphoma kinase (ALK) gene that has spread to other parts of the body. Lorlatinib, an anticancer drug developed by Pfizer Inc. and marketed as Lorbrena in the United States, Canada and Japan and Lorviqua in the European Union, is an oral inhibitor of ALK and ROS1, two enzymes that play a role in the development of cancer.

Before patients take the drug, their healthcare provider will perform a test to make sure lorlatinib is right for the patient. It is not known whether lorlatinib is safe and effective in children. Lorlatinib is available as oral tablets containing 25 mg or 100 mg of lorlatinib with a recommended dose of 100 mg once daily. If certain side effects occur, your doctor may reduce the dose or temporarily interrupt treatment. If the disease worsens or side effects become too severe, treatment may be stopped entirely.

The common specifications of the lorlatinib original drug that is domestically marketed and covered by medical insurance may include 25mg*90 tablets and 100mg*30 tablets. It is roughly estimated that patients need to use about one box per month. The price of domestically marketed drugs per box is between 10,000 and 20,000 yuan, and the Hong Kong version of the original drug is between 30,000 and 50,000 yuan per box, which is still relatively expensive. For lorlatinib generic drugs sold overseas, patients may only need about 3,000 yuan for one month's use. Compared with the original drug, the price is much cheaper. For more information on overseas drug prices and related information, please consult Yaode Medical Consultants.